Alessandrea C. Quane - Jun 5, 2024 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
EVP, Chief Insurance Officer
Signature
/s/ Melissa Curtin, Attorney-in-Fact
Stock symbol
OSCR
Transactions as of
Jun 5, 2024
Transactions value $
-$328,807
Form type
4
Date filed
6/7/2024, 04:23 PM
Previous filing
Jun 4, 2024
Next filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +31.3K +13.2% 268K Jun 5, 2024 Direct F1
transaction OSCR Class A Common Stock Sale -$329K -16.8K -6.27% $19.58 251K Jun 6, 2024 Direct F2, F3
holding OSCR Class A Common Stock 76.9K Jun 5, 2024 Alessandrea C Quane 2024 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -31.3K -33.33% $0.00 62.5K Jun 5, 2024 Class A Common Stock 31.3K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.45 to $19.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.